[Federal Register Volume 78, Number 207 (Friday, October 25, 2013)]
[Notices]
[Page 64018]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2013-25085]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances, Notice of Application, 
Research Triangle Institute

    Pursuant to Sec.  1301.33(a), Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on July 25, 2013, Research 
Triangle Institute, Hermann Building East Institute Drive, P.O. Box 
12194, Research Triangle Park, North Carolina 27709, made application 
by letter to the Drug Enforcement Administration (DEA) to be registered 
as a bulk manufacturer of Tetrahydrocannabinols (7370), a class of 
controlled substance listed in schedule I.
    The company plans to provide small quantities to commercial 
customers for use in preparing test kits, reagents, and reference 
standards.
    The company plans to bulk manufacture a synthetic 
Tetrahydrocannabinol. No other activity for this drug code is 
authorized for this registration.
    Any other such applicant, and any person who is presently 
registered with DEA to manufacture such substances, may file comments 
or objections to the issuance of the proposed registration pursuant to 
21 CFR 1301.33(a).
    Any such written comments or objections should be addressed, in 
quintuplicate, to the Drug Enforcement Administration, Office of 
Diversion Control, Federal Register Representative (ODW), 8701 
Morrissette Drive, Springfield, Virginia 22152; and must be filed no 
later than December 24, 2013.

     Dated: October 10, 2013.
 Joseph T. Rannazzisi,
 Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2013-25085 Filed 10-24-13; 8:45 am]
BILLING CODE 4410-09-P